Newsletter
Asia’s largest dialysis network, under the brand NephroPlus, is preparing to file papers for a ₹2,000 crore IPO this month.
The deets: Nephrocare Health Services operates more than 447 dialysis centres across India and has a presence in Philippines, Uzbekistan and Nepal. The proposed IPO will be a mix of fresh issue and offer-for sale.
The why: the company plans to use the proceeds from the IPO to scale operations, including acquisitions of mid-sized dialysis firms in India and the Philippines.
Zoom out: India’s dialysis market is projected to grow to $870 million by 2030. NephroPlus commands over 50% market share in the organised segment, benefitting from long-term public-private partnership contracts and partnerships with leading hospital chains such as Max Healthcare, Fortis, and Medanta.
The big picture: with rising kidney disease linked to diabetes and hypertension, India faces a growing need for accessible dialysis care especially beyond major cities. NephroPlus is bridging this gap with tech-enabled, standardized services.
